David Joseph Muehlbauer

Title: David Joseph Muehlbauer: Innovator in Pharmaceutical Compositions

Introduction

David Joseph Muehlbauer is a notable inventor based in North Stonington, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions aimed at improving patient care.

Latest Patents

Muehlbauer holds a patent for "Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions." This patent describes two crystalline polymorphic forms, known as Form I and Form II, of a specific compound. The pharmaceutical composition that includes at least one of these polymorphs demonstrates advantageous stability for formulations intended to treat emesis in patients undergoing chemotherapy. The administration methods for this composition are conventional oral routes, preferably in tablet or capsule form, or through intravenous delivery. Additionally, the patent discloses a method for producing Forms I and II.

Career Highlights

Muehlbauer is associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on developing innovative solutions that enhance the effectiveness of treatments for patients.

Collaborations

Muehlbauer has collaborated with notable colleagues, including Douglas J M Allen and Troy Anthony Appleton. These collaborations have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

David Joseph Muehlbauer is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact patient treatment options. His innovative approach and collaboration with esteemed colleagues highlight his commitment to advancing healthcare solutions.